Literature DB >> 20027991

Effects of decentration of photorefractive keratectomy on the induction of higher order wavefront aberrations.

Sang-Bumm Lee1, Bo-Sung Hwang, Junyeop Lee.   

Abstract

PURPOSE: To evaluate the effects of ablation decentration on the induction of higher order wavefront aberrations (HOAs) in active eye-tracker-assisted myopic photorefractive keratectomy (PRK) using the VISX STAR S4 laser with ActiveTrak (Abbott Medical Optics [AMO]).
METHODS: Ninety-four myopic eyes (53 patients) were divided into three groups according to ablation decentration (group 1, ≤0.15 mm, 20 eyes; group 2, >0.15 to ≤0.30 mm, 54 eyes; and group 3, >0.30 mm, 20 eyes). The distances of ablation centers from the centers of the entrance pupils were analyzed using corneal topography. Wavefront errors were measured preoperatively and at 6 months after PRK using a VISX WaveScan aberrometer (AMO). Statistical analysis was performed to assess the influence of ablation decentration on PRK-induced HOAs.
RESULTS: The mean decentration was 0.23±0.10 mm (range: 0.04 to 0.52 7 mm). The magnitude of all HOAs was significantly increased at 6 months postoperatively (P<.05). Increases in PRK-induced HOAs including total HOA, coma, and spherical aberration were significantly different among the three groups (P<.05). Statistically significant differences were noted between pairs of data in group 1 versus group 3 for total HOA (P=.015), coma (P=.038), and spherical aberration (P=.038), and group 2 versus group 3 for coma (P=.049).
CONCLUSIONS: Ablation decentration >0.30 mm from the center of the entrance pupil was associated with greater induction of total HOA, coma, and spherical aberration after PRK, as compared with ablation decentration <0.15 mm. In addition, ablation decentration has a more significant influence on coma-inducing effects. Copyright 2010, SLACK Incorporated.

Entities:  

Mesh:

Year:  2009        PMID: 20027991     DOI: 10.3928/1081597X-20091209-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  7 in total

1.  Effect of Iris registration on visual outcome in wavefront-guided LASEK for myopic astigmatism.

Authors:  Jong Joo Lee; Mee Kum Kim; Won Ryang Wee
Journal:  Int Ophthalmol       Date:  2017-03-11       Impact factor: 2.031

Review 2.  Clinical outcomes of corneal refractive surgery comparing centration on the corneal vertex with the pupil center: a meta-analysis.

Authors:  Jiamei Zhang; Yan Wang; Xiaoqin Chen; Wenjing Wu
Journal:  Int Ophthalmol       Date:  2020-07-15       Impact factor: 2.031

3.  Long-Term Observation of Higher-Order Aberrations and Microdistortions in Bowman's Layer After Small Incision Lenticule Extraction for the Correcting Myopia With Spherical Equivalent Higher Than -9.0 Diopters.

Authors:  Xueyi Zhou; Bing Qin; Tian Han; Jianmin Shang; Zhuoyi Chen; Jing Zhao; Peijun Yao; Xingtao Zhou
Journal:  Front Med (Lausanne)       Date:  2022-04-08

4.  Impact of Treatment Decentration on Higher-Order Aberrations after SMILE.

Authors:  Ying Yu; Wenwen Zhang; Xinliang Cheng; Jianru Cai; Hui Chen
Journal:  J Ophthalmol       Date:  2017-03-15       Impact factor: 1.909

5.  Wavefront properties of the anterior and posterior corneal surface after transepithelial photorefractive keratectomy in myopia.

Authors:  Lei Xi
Journal:  Exp Ther Med       Date:  2019-12-17       Impact factor: 2.447

6.  Prospective, Randomized, Contralateral Eye Comparison of Functional Optical Zone, and Visual Quality After SMILE and FS-LASIK for High Myopia.

Authors:  Shengyu He; Yiqi Luo; Pei Chen; Yiming Ye; Hua Zheng; Min Lan; Jing Zhuang; Keming Yu
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

7.  Clinical Outcomes of Aberration-Free All Surface Laser Ablation (ASLA) vs. Aberration-Free ASLA Assisted by Smart Pulse Technology in High Myopia: A One-Year Follow-Up Study.

Authors:  XiaoHao Du; Jia Zhang; Meng Su; WenJia Cao; Shuang Zeng; QinMei Wang; Ioannis M Aslanides; ShiHao Chen
Journal:  J Ophthalmol       Date:  2021-10-18       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.